Pharmacological treatment for the novel coronavirus disease 2019 (COVID-19 infection)
© Faculty of Pharmacy, Mahidol University (Thailand) 2020. As of March 22, 2020, a total of 292,142 confirmed coronavirus disease 2019 (COVID-19) cases have been reported globally. Although there are currently no specific antiviral agents but all coronaviruses shared similar key elements of target f...
Saved in:
Main Authors: | , , |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85085214601&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70954 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
id |
th-cmuir.6653943832-70954 |
---|---|
record_format |
dspace |
spelling |
th-cmuir.6653943832-709542020-10-14T08:48:07Z Pharmacological treatment for the novel coronavirus disease 2019 (COVID-19 infection) Nattapong Tidwong Preecha Montakantikul Weerawat Manosuthi Medicine Pharmacology, Toxicology and Pharmaceutics © Faculty of Pharmacy, Mahidol University (Thailand) 2020. As of March 22, 2020, a total of 292,142 confirmed coronavirus disease 2019 (COVID-19) cases have been reported globally. Although there are currently no specific antiviral agents but all coronaviruses shared similar key elements of target for currently approved antiviral or new drug development. Several agents might be considered as a possible treatment based on the efficacy in SARS and MERS. 2020-10-14T08:45:29Z 2020-10-14T08:45:29Z 2020-01-01 Journal 25868470 25868195 2-s2.0-85085214601 10.29090/psa.2020.02.020.0026 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85085214601&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70954 |
institution |
Chiang Mai University |
building |
Chiang Mai University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Chiang Mai University Library |
collection |
CMU Intellectual Repository |
topic |
Medicine Pharmacology, Toxicology and Pharmaceutics |
spellingShingle |
Medicine Pharmacology, Toxicology and Pharmaceutics Nattapong Tidwong Preecha Montakantikul Weerawat Manosuthi Pharmacological treatment for the novel coronavirus disease 2019 (COVID-19 infection) |
description |
© Faculty of Pharmacy, Mahidol University (Thailand) 2020. As of March 22, 2020, a total of 292,142 confirmed coronavirus disease 2019 (COVID-19) cases have been reported globally. Although there are currently no specific antiviral agents but all coronaviruses shared similar key elements of target for currently approved antiviral or new drug development. Several agents might be considered as a possible treatment based on the efficacy in SARS and MERS. |
format |
Journal |
author |
Nattapong Tidwong Preecha Montakantikul Weerawat Manosuthi |
author_facet |
Nattapong Tidwong Preecha Montakantikul Weerawat Manosuthi |
author_sort |
Nattapong Tidwong |
title |
Pharmacological treatment for the novel coronavirus disease 2019 (COVID-19 infection) |
title_short |
Pharmacological treatment for the novel coronavirus disease 2019 (COVID-19 infection) |
title_full |
Pharmacological treatment for the novel coronavirus disease 2019 (COVID-19 infection) |
title_fullStr |
Pharmacological treatment for the novel coronavirus disease 2019 (COVID-19 infection) |
title_full_unstemmed |
Pharmacological treatment for the novel coronavirus disease 2019 (COVID-19 infection) |
title_sort |
pharmacological treatment for the novel coronavirus disease 2019 (covid-19 infection) |
publishDate |
2020 |
url |
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85085214601&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70954 |
_version_ |
1681752996752392192 |